GENE ONLINE|News &
Opinion
Blog

2016-12-09| Interviews

Dr. Johnsee Lee observes the survival challenges of biotech industry in Taiwan among the global intense competitors (Part One).

by Editor-Jane
Share To
After viewing the tremendous experiences of Dr. Johnsee Lee (李鍾熙), the Honorary Director of Taiwan Bio Industry Organization, I believe he is the most suitable candidate to provide advises on the tasks and challenges the biotech industry in Taiwan now faces. GeneOnline is honored to have the opportunity to interview Dr. Lee at the beginning of 2016, and to have him talk about the development of the global biotech industry and the forecast of the Taiwan biomedical industry, hoping that we can find our standpoint in the global market through his penetrating analysis and point of views.

It's free! Log in now to read

LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top